G
LIVE

Serial Number

97446036

Owner

SMITHKLINE BEECHAM LIMITED

Attorney

Christopher M. Hanes

Filing Date

Jun 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

G Trademark

Serial Number: 97446036

G is a trademark filed by SMITHKLINE BEECHAM LIMITED on June 7, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

SMITHKLINE BEECHAM LIMITED (176 trademarks)

980 GREAT WEST ROAD
BRENTFORD, MIDDLESEX TW8 9GS , GB

Entity Type: 11

Trademark Details

Filing Date

June 7, 2022

Registration Date

Not Registered

Published for Opposition

July 25, 2023

Goods & Services

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; adjuvants for medical purposes; medicated and sanitizing soaps and detergents

Medical and healthcare services; provision of medical information and medical services; information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments; gene and cell therapy medical treatment services; genetic testing for medical purposes; provision of information, consultancy and advisory services relating to any of the aforesaid services

Surgical apparatus and instruments for medical use; medical fluid injectors; medical apparatus and instruments for use in the diagnosis and treatment of skin diseases, conditions and disorders; transcutaneous electrical nerve stimulation devices to treat body pain; implantable electrodes for medical purposes; adaptive open and or closed-loop bioelectronic medical devices that deliver stimulation and/or blocking to a nerve and optionally can record incoming action potentials and physiological parameters, analyze data in real time and modulate neural signaling; drug delivery devices sold empty, namely, syringes for medical purposes and for injections; surgical implants comprising artificial material

Scientific research for medical purposes in the field of pharmaceuticals, vaccines, cell and gene therapy; research and development services in the fields of bioelectronics, drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biochemicals, biotechnology, biological products, medical apparatus, devices and instruments; conducting genetic testing for research purposes; scientific research consulting; medical laboratory services; Providing medical and scientific research information; computer system design services in the nature of design of computational models and systems of artificial intelligence; medical and pharmacological research services; software development, programming and implementation; research in the field of gene and cell therapy; provision of information, consultancy and advisory services relating to any of the aforesaid services

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 11, 2025 EXRA
SOU EXTENSION 4 GRANTED
Sep 10, 2025 EX4G
SOU EXTENSION 4 FILED
Sep 10, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 10, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 13, 2025 EXRA
SOU EXTENSION 3 GRANTED
Mar 12, 2025 EX3G
SOU EXTENSION 3 FILED
Mar 12, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 12, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 23, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 23, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 23, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 11, 2024 EXRA
SOU EXTENSION 2 GRANTED
Sep 11, 2024 EX2G
SOU EXTENSION 2 FILED
Sep 11, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 11, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 6, 2024 EXRA
SOU EXTENSION 1 GRANTED
Mar 5, 2024 EX1G
SOU EXTENSION 1 FILED
Mar 5, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 5, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 19, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 25, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 22, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 21, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 24, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2023 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 2, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 2, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 2, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 2, 2022 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 15, 2022 NWOS
NEW APPLICATION ENTERED
Jun 10, 2022 NWAP